The Korean Neonatal Network: An Overview.
10.3346/jkms.2015.30.S1.S3
- Author:
Yun Sil CHANG
1
;
Hyun Young PARK
;
Won Soon PARK
Author Information
1. Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. wonspark@skku.edu
- Publication Type:Research Support, Non-U.S. Gov't ; Review
- Keywords:
Infant, Premature;
Infant, Very-Low-Birth-Weight;
Quality Improvement
- MeSH:
Humans;
Infant, Newborn;
Infant, Premature;
Infant, Very Low Birth Weight;
Intensive Care Units, Neonatal;
Quality Improvement;
Registries;
Republic of Korea;
Societies, Medical/*organization & administration
- From:Journal of Korean Medical Science
2015;30(Suppl 1):S3-S11
- CountryRepublic of Korea
- Language:English
-
Abstract:
Currently, in the Republic of Korea, despite the very-low-birth rate, the birth rate and number of preterm infants are markedly increasing. Neonatal deaths and major complications mostly occur in premature infants, especially very-low-birth-weight infants (VLBWIs). VLBWIs weigh less than 1,500 g at birth and require intensive treatment in a neonatal intensive care unit (NICU). The operation of the Korean Neonatal Network (KNN) officially started on April 15, 2013, by the Korean Society of Neonatology with support from the Korea Centers for Disease Control and Prevention. The KNN is a national multicenter neonatal network based on a prospective web-based registry for VLBWIs. About 2,000 VLBWIs from 60 participating hospital NICUs are registered annually in the KNN. The KNN has built unique systems such as a web-based real-time data display on the web site and a site-visit monitoring system for data quality surveillance. The KNN should be maintained and developed further in order to generate appropriate, population-based, data-driven, health-care policies; facilitate active multicenter neonatal research, including quality improvement of neonatal care; and ultimately lead to improvement in the prognosis of high-risk newborns and subsequent reduction in health-care costs through the development of evidence-based neonatal medicine in Korea.
